Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Affect Therapeutics logo — Digital treatment for alcohol & drug addiction delivered thr...

Affect Therapeutics

Digital treatment for alcohol & drug addiction delivered through a revolutionary smartphone app that motivates recovery

Founded 2020 United States United States 115 employees Series A Total: $23.00M Health Care, Health and Wellness +1

General Information

Company Name Affect Therapeutics
Founded Year 2020
Location United States United States
Founders / Decision Makers
Team member
Employees 115
Industries Health Care, Health and Wellness, Sports
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Affect Therapeutics. To contact Affect Therapeutics, visit affecttherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Affect Therapeutics compare?

A PDF of Affect Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Affect Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Affect Therapeutics

Affect Therapeutics is a health care startup that provides digital treatment for alcohol and drug addiction through a revolutionary smartphone app. Utilizing contingency management and rewards systems, the app leverages behavioral engineering and gamification principles to stimulate the brain's rewards center, helping individuals reduce their substance use and manage addiction. Accredited by CARF International and supported by NIDA and NIH, Affect's program and technology achieve outcomes more than double of traditional rehab models. The company received a $16.00M Series A investment on July 12, 2023, with investors including City Light Capital, AlleyCorp, Samsung NEXT, LifeArc, Whatif Ventures, and Artis Ventures (AV). Affect Therapeutics aims to make its program accessible to communities without clinics and offers partnership opportunities for organizations addressing the addiction crisis. The company's innovative approach to addiction treatment and strong investor support positions it as an influential player in the healthcare industry.

Business keywords: Substance Use Disorder Treatment, Digital Health, Mobile App, Addiction Recovery, Behavioral Engineering, Gamification, CARF Accreditation, Harm Reduction, Continuum of Care, Healthcare Partnerships, Medicaid Coverage, Insurance Plans, Referral Network, Clinical Research

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.00M 6
City Light Capital AlleyCorp Samsung NEXT
City Light Capital, AlleyCorp +4
12 Jul 2023
Series A Undisclosed 4
Kapor Capital AlleyCorp Whatif Ventures
Kapor Capital, AlleyCorp +2
01 Feb 2023
Seed Round $6.00M -
23 Jul 2021
Seed Round $1.00M -
21 Apr 2021

Affect Therapeutics Alternatives & Competitors

View All Alternatives
Affect Therapeutics vs
Boulder Care
Boulder Care United States

Telehealth addiction treatment on your terms and timeline - grounded in kindness, respect, and uncon...

Series C
205 employees
Health Care, Health and Wellness
Compare Affect Therapeutics vs Boulder Care
Affect Therapeutics vs
Workit Health
Workit Health United States

Combining technology and compassionate care, Workit Health makes it easier to recover from substance...

Grant
212 employees
Health Care, Health and Wellness
Compare Affect Therapeutics vs Workit Health
Affect Therapeutics vs
Odyssey Behavioral Healthcare
Odyssey Behavioral Healthcare United States

Behavioral Health Treatment Centers

142 employees
Health Care, Health and Wellness
Also compare with: Affect Therapeutics vs Better Life Partners Better Life Partners View all alternatives

FAQ About Affect Therapeutics

Digital treatment for alcohol & drug addiction delivered through a revolutionary smartphone app that motivates recovery
Affect Therapeutics was founded in 2020.
Affect Therapeutics is headquartered in United States.
Affect Therapeutics operates in Health Care, Health and Wellness and Sports. Its work centres on Substance Use Disorder Treatment, Digital Health, Mobile App and Addiction Recovery.
Affect Therapeutics has approximately 115 employees.
Affect Therapeutics has completed 4 funding rounds, raising a total of $23.00M. The latest funding stage is Series A.
Top alternatives and competitors to Affect Therapeutics include Boulder Care, Workit Health, Odyssey Behavioral Healthcare, Spero Health, Better Life Partners. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Affect Therapeutics and Boulder Care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Affect Therapeutics, https://bouncewatch.com/company/affect-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout